Sclerosis, Systemic: Clinical Trials

1 trial for Sclerosis, Systemic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Sclerosis, Systemic: new trials by email Literature Review of Sclerosis, Systemic trials Research Report on Sclerosis, Systemic

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of FT011 in Systemic Sclerosis
FT011, Placebo - Scleroderma, Systemic, Scleroderma, Diffuse
Phase 2CompletedCerta Therapeutics302021-07-192023-12-20

Narrower conditions

Scleroderma, Diffuse (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Connective Tissue Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

FT011 (1)

Sponsors

Certa Therapeutics (1)

Countries

Australia (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  Ukraine (1)

Top investigators

Darren Kelly, PhD (1)